Woodline Partners LP

Position in IMCR — Immunocore Holdings plc

CIK 1784547 San Francisco, CA

Position in IMCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,550,374

-$1,441,762 QoQ

Shares Held

316,762

+0.0% QoQ

Ownership

0.623%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,423,987,323 across 188 Biotechnology names. IMCR ranks #85 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,550,374	316,762	+0.0%	Shares	Sole	2026-05-15
2025-12-31	$10,992,136	316,685	+52.7%	Shares	Sole	2026-02-17
2025-09-30	$7,536,222	207,438	-15.8%	Shares	Sole	2025-11-14
2025-06-30	$7,735,107	246,498	-24.9%	Shares	Sole	2025-08-14
2025-03-31	$9,739,029	328,245	+0.1%	Shares	Sole	2025-05-15
2024-12-31	$9,677,740	328,059	+19.4%	Shares	Sole	2025-02-14
2024-09-30	$8,550,819	274,681	+0.2%	Shares	Sole	2024-11-14
2024-06-30	$9,287,147	274,038	0.0%	Shares	Sole	2024-08-14
2024-03-31	$17,812,470	274,038	+173.1%	Shares	Sole	2024-05-15
2023-12-31	$6,854,408	100,328	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.